Flemming Forsberg, phD

Magnetic Resonance Imaging

Quality-of-Life Assessment

phase_1_2

flemming-forsberg

SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane microbubbles)

phase_1_2

flemming-forsberg

phase_2

3D HI and SHI of UCA

phase_4

Dynamic Contrast-Enhanced Ultrasound Imaging

sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university

early_phase_1

SHAPE measurement using the ultrasound contrast agent Lumason (sulfur hexafluoride lipid-type A microspheres)

phase_2

SHAPE measurement (Definity ultrasoud contrast agent)

phase_3

Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal

+13 more interventions

21 unique interventions2 categories

Analytics

Trial Phases

Phase 11

Phase 24

Phase 32

Phase 42

Trial Status

Completed6

Recruiting1

Other2

Role Distribution

Principal Investigator9

PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT05470205Phase 3Recruiting

Liver DiseasesPortal Hypertension

PrincipalinvestigatorStart date: 2022-11-28

NCT04821284Phase 1/2Active Not Recruiting

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+5 more

PrincipalinvestigatorStart date: 2021-12-06

NCT04720456Phase 2Completed

SHAPE of Portal Hypertension in Children

Hypertension, Portal

PrincipalinvestigatorStart date: 2021-11-03

NCT05247541Phase 2/3Completed

Diagnosing Compartment Syndrome With SHAPE vs Elastography

Chronic Exertional Compartment Syndrome

PrincipalinvestigatorStart date: 2020-07-01

NCT02967458Phase 2Completed

Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study

Prostatic Neoplasm

PrincipalinvestigatorStart date: 2017-02-01

NCT02489045Phase 4Completed

Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension

Liver DiseasesPortal Hypertension

PrincipalinvestigatorStart date: 2015-04-06

NCT02671552Early Phase 1Withdrawn

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery

Renal Cell Carcinoma

PrincipalinvestigatorStart date: 2013-01-24

NCT01490892Phase 4Completed

Quantitative Subharmonic Breast Imaging

Breast Cancer

Principalinvestigator

NCT02115607Not ApplicableCompleted

Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy

Breast Cancer

Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Hypertension, Portal3 Breast Cancer2 Liver Diseases2 Chronic Exertional Compartment Syndrome1 Locally Advanced Pancreatic Ductal Adenocarcinoma1 Metastatic Pancreatic Ductal Adenocarcinoma1 Prostatic Neoplasms1 Carcinoma, Renal Cell1

Affiliations

Thomas Jefferson University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ethan J Halpern, MD

Thomas Jefferson University

1 trials

Shared therapeutic areas:

Prostatic Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)Thomas Jefferson University

Collaborated on 1 trial

Similarity Score14%

Sudha A Anupindi, MD

Children's Hospital of Philadelphia

1 trials

Shared therapeutic areas:

Hypertension, Portal

Worked with same sponsors:

Children's Hospital of PhiladelphiaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)+1 more

Collaborated on 1 trial

Similarity Score14%

Lizhi Niu, PhD

Fuda Cancer Hospital

31 trials

Shared therapeutic areas:

Breast CancerProstatic Neoplasms

Hypertension, PortalLiver Diseases

Xiaolong Qi, MD

LanZhou University

8 trials

Shared therapeutic areas:

Breast CancerCarcinoma, Renal Cell

Michael B Gill

Power Life Sciences Inc.

105 trials

Shared therapeutic areas:

Breast CancerCarcinoma, Renal Cell

David Avigan, MD

Beth Israel Deaconess Medical Center

17 trials

Shared therapeutic areas:

Worked with same sponsors:

National Cancer Institute (NCI)

Dong-Xin Wang, MD, PhD

Peking University First Hospital

74 trials

Shared therapeutic areas:

Breast Cancer

Ali MA Ismail, lecturer

Cairo University

27 trials

Shared therapeutic areas:

Breast Cancer

Jeong Min Lee, MD

Seoul National University Hospital

34 trials

Shared therapeutic areas:

Liver Diseases

National Cancer Institute (NCI)

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

Breast Cancer

Worked with same sponsors: